The ROE as of December 2025 (TTM) for Invizyne Technologies Inc. Common Stock (IZTC) is -127.54%

According to Invizyne Technologies Inc. Common Stock’s latest financial reports and current stock price. The company's current ROE is -127.54%. This represents a change of 288.52% compared to the average of -32.83% of the last 4 quarters.

Invizyne Technologies Inc. Common Stock (IZTC) Historical ROE (quarterly & annually)

How has IZTC ROE performed in the past?

The mean historical ROE of Invizyne Technologies Inc. Common Stock over the last ten years is 67.86%. The current -127.54% ROE has changed -287.97% with respect to the historical average. Over the past ten years (40 quarters), IZTC's ROE was at its highest in in the December 2023 quarter at 285.85%. The ROE was at its lowest in in the September 2023 quarter at -85.75%.

Invizyne Technologies Inc. Common Stock (IZTC) ROE by Quarter and Year

Discovering the peaks and valleys of Invizyne Technologies Inc. Common Stock ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Invizyne Technologies Inc. Common Stock (IZTC) Average ROE

How has IZTC ROE performed in the past?

The current ROE of Invizyne Technologies Inc. Common Stock (IZTC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Invizyne Technologies Inc. Common Stock (IZTC) ROE vs. Peers

How is IZTC’s ROE compared to its peers?

Invizyne Technologies Inc. Common Stock’s ROE is greater than F-star Therapeutics, Inc. (-44.74%), greater than Pardes Biosciences, Inc. (-41.86%), less than Selecta Biosciences, Inc. (754.65%), greater than Quoin Pharmaceuticals, Ltd. (-210.51%), greater than Theseus Pharmaceuticals, Inc. (-20.74%), less than Theratechnologies Inc. (37.63%), greater than aTyr Pharma, Inc. (-100.11%), less than Sesen Bio, Inc. (86.43%), less than Paratek Pharmaceuticals, Inc. (42.54%), greater than LENZ Therapeutics, Inc. (-25.63%),

Build a custom stock screener for Invizyne Technologies Inc. Common Stock (IZTC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Invizyne Technologies Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Invizyne Technologies Inc. Common Stock (IZTC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Invizyne Technologies Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.